NCT05644808Active, not recruiting
MYLUNG Consortium Study Protocol 2
Molecularly Informed Lung Cancer Treatment in a Community Cancer Network: A Pragmatic Prospective RWE Study (MYLUNG Consortium: Part 2)
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
This pragmatic study looks to quantify the testing timeline, operational barriers, and outcomes of biomarker-guided therapy in a large, community-based, and largely unselected patient population with early stage and advanced stage, treatment-naive non-small cell lung cancer, whether squamous or non-squamous.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 1002 (actual)
- First submitted
- 30 Nov 2022
- Start date
- 29 Dec 2020
- Primary completion date
- Sept 2027
- Lead sponsor
- US Oncology Research
- Diseases
- Lung cancer
- NCT number
- NCT05644808
What you commit to
- Study type: Observational
- Participants enrolled: 1002
- From 29 Dec 2020 to the primary completion date, Sept 2027
- 18 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Subjects with small cell lung cancer
Other
- Stage IA at the time of enrollment
- Subjects with Unknown primary tumor origin
Who the study is looking for
- Adult subjects (18 years and older) with newly diagnosed early stage, locally advanced or metastatic non-small cell lung cancer
- Eligible for systemic therapy based on the treating provider's assessment
- Subjects who developed locally advanced or metastatic disease after receiving adjuvant or neoadjuvant therapy are eligible if the adjuvant/neoadjuvant therapy was completed at least 12 months prior to the development of locally advanced or metastatic disease
- Subjects may be enrolled within 30 days of initiation of systemic therapy
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (18)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Texas Oncology - West Texas Coordinator of this site? Confirm its status | Abilene | United States | Unknown status |
| New York Oncology Hematology, P.C. Coordinator of this site? Confirm its status | Albany | United States | Unknown status |
| Texas Oncology- DFWW Coordinator of this site? Confirm its status | Arlington | United States | Unknown status |
| Oncology Hematology Care Clinical Trials LLC Coordinator of this site? Confirm its status | Cincinnati | United States | Unknown status |
| Texas Oncology - Baylor Charles A. Sammons Cancer Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Texas Oncology-Dallas Presbyterian Hospital Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| Southern Cancer Center Pc Coordinator of this site? Confirm its status | Daphne | United States | Unknown status |
| Rocky Mountain Cancer Center Coordinator of this site? Confirm its status | Denver | United States | Unknown status |
| Willamette Valley Cancer Institute and Research Center Coordinator of this site? Confirm its status | Eugene | United States | Unknown status |
| Virginia Cancer Specialists PC Coordinator of this site? Confirm its status | Fairfax | United States | Unknown status |
| Texas Oncology - Fort Worth Cancer Center Coordinator of this site? Confirm its status | Fort Worth | United States | Unknown status |
| Texas Oncology-McAllen Coordinator of this site? Confirm its status | McAllen | United States | Unknown status |
| Minnesota Oncology Hematology, P.A. Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
| Virginia Oncology Associates Coordinator of this site? Confirm its status | Newport News | United States | Unknown status |
| Illinois Cancer Specialists Coordinator of this site? Confirm its status | Niles | United States | Unknown status |
| Woodlands Medical Specialists, PA Coordinator of this site? Confirm its status | Pensacola | United States | Unknown status |
| Maryland Oncology Hematology P.A. Coordinator of this site? Confirm its status | Silver Spring | United States | Unknown status |
| Texas Oncology - Northeast Texas Coordinator of this site? Confirm its status | Tyler | United States | Unknown status |
Related publications
- Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices.JCO Precis Oncol · 2026 · PMID 42018966
This page is information, not medical advice. Discuss any trial with your doctor.